We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Aptiv (APTV) to Report Q1 Earnings: What's in the Offing?
Read MoreHide Full Article
Aptiv PLC (APTV - Free Report) is set to report first-quarter 2021 results on May 6, before the bell.
The company has an impressive earnings surprise history. It surpassed the Zacks Consensus Estimate in all of the last four quarters, delivering an average surprise of 48.5%.
Q1 Expectations
The Zacks Consensus Estimate for revenues is pegged at $3.69 billion, indicating year-over-year growth of 14.5%. The top line is likely to have benefited from growth in both Advanced Safety & User Experience, and Signal & Power Solutions segments’ revenues.
The consensus estimate for Advanced Safety & User Experience revenues is pegged at $1.06 billion, indicating year-over-year increase of 17.1%. The consensus mark for Signal & Power Solutions segment’s revenues stands at $2.6 billion, signaling year-over-year growth of 12.7%
The consensus estimate for earnings is pinned at 77 cents, indicating year-over-year increase of 13.2%. Revenue growth and cost management are likely to have benefited the bottom line in the quarter.
What Our Model Says
Our proven model does not conclusively predict an earnings beat for Aptiv this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Aptiv has an Earnings ESP of -6.16% and a Zacks Rank #3.
Here are a few stocks from the broader Zacks Business Services sector that investors may consider, as our model shows that these have the right combination of elements to beat on earnings this season.
Clear Channel Outdoor (CCO - Free Report) , with an Earnings ESP of +30.67% and a Zacks Rank of 3.
Fidelity National Information Services (FIS - Free Report) has an Earnings ESP of +2.01% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Aptiv (APTV) to Report Q1 Earnings: What's in the Offing?
Aptiv PLC (APTV - Free Report) is set to report first-quarter 2021 results on May 6, before the bell.
The company has an impressive earnings surprise history. It surpassed the Zacks Consensus Estimate in all of the last four quarters, delivering an average surprise of 48.5%.
Q1 Expectations
The Zacks Consensus Estimate for revenues is pegged at $3.69 billion, indicating year-over-year growth of 14.5%. The top line is likely to have benefited from growth in both Advanced Safety & User Experience, and Signal & Power Solutions segments’ revenues.
The consensus estimate for Advanced Safety & User Experience revenues is pegged at $1.06 billion, indicating year-over-year increase of 17.1%. The consensus mark for Signal & Power Solutions segment’s revenues stands at $2.6 billion, signaling year-over-year growth of 12.7%
The consensus estimate for earnings is pinned at 77 cents, indicating year-over-year increase of 13.2%. Revenue growth and cost management are likely to have benefited the bottom line in the quarter.
What Our Model Says
Our proven model does not conclusively predict an earnings beat for Aptiv this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Aptiv has an Earnings ESP of -6.16% and a Zacks Rank #3.
Aptiv PLC Price and EPS Surprise
Aptiv PLC price-eps-surprise | Aptiv PLC Quote
Stocks That Warrant a Look
Here are a few stocks from the broader Zacks Business Services sector that investors may consider, as our model shows that these have the right combination of elements to beat on earnings this season.
BGSF (BGSF - Free Report) has an Earnings ESP of +33.33% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Clear Channel Outdoor (CCO - Free Report) , with an Earnings ESP of +30.67% and a Zacks Rank of 3.
Fidelity National Information Services (FIS - Free Report) has an Earnings ESP of +2.01% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>